AR100977A1 - Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación - Google Patents

Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación

Info

Publication number
AR100977A1
AR100977A1 ARP150102016A ARP150102016A AR100977A1 AR 100977 A1 AR100977 A1 AR 100977A1 AR P150102016 A ARP150102016 A AR P150102016A AR P150102016 A ARP150102016 A AR P150102016A AR 100977 A1 AR100977 A1 AR 100977A1
Authority
AR
Argentina
Prior art keywords
rosuvastatin
portion corresponding
ezetimibe
composite formulation
mixture
Prior art date
Application number
ARP150102016A
Other languages
English (en)
Spanish (es)
Inventor
Soo Woo Jong
Hyun Park Jae
Jun Lee Seung
Soo Kim Kyeong
Young Jeong Ha
Il Kim Yong
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54938391&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR100977(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of AR100977A1 publication Critical patent/AR100977A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP150102016A 2014-06-25 2015-06-24 Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación AR100977A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140078388A KR101977785B1 (ko) 2014-06-25 2014-06-25 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법

Publications (1)

Publication Number Publication Date
AR100977A1 true AR100977A1 (es) 2016-11-16

Family

ID=54938391

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102016A AR100977A1 (es) 2014-06-25 2015-06-24 Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación

Country Status (10)

Country Link
KR (1) KR101977785B1 (ko)
AR (1) AR100977A1 (ko)
BR (1) BR112016030111A2 (ko)
CL (1) CL2016003283A1 (ko)
EC (1) ECSP16096477A (ko)
JO (1) JOP20150154B1 (ko)
SG (2) SG10201811586YA (ko)
TW (1) TWI700100B (ko)
UY (1) UY36190A (ko)
WO (1) WO2015199356A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2016539A3 (cs) 2016-09-05 2018-03-14 Zentiva, K.S. Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy
CZ2016538A3 (cs) 2016-09-05 2018-03-14 Zentiva, K.S. Farmaceutická kompozice obsahující dvě rozdílné účinné látky
KR102206535B1 (ko) * 2016-11-29 2021-01-22 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합정제
EP3437636A1 (en) * 2017-08-02 2019-02-06 Adamed sp. z o.o. Pharmaceutical composition comprising ezetimibe
KR102500643B1 (ko) * 2019-04-18 2023-02-16 한미약품 주식회사 에제티미브 및 로사르탄을 포함하는 약제학적 복합제제
KR20200137243A (ko) 2019-05-29 2020-12-09 콜마파마(주) 로수바스타틴 및 에제티미브를 포함하는 복합제의 제조방법
WO2021019499A1 (en) 2019-07-31 2021-02-04 TECNIMEDE - Sociedade Técnico-medicinal, SA Solid oral multiple-unit immediate release compositions, methods and uses thereof
BR112023003323A2 (pt) * 2020-08-25 2023-03-21 Daewoong Pharmaceutical Co Ltd Composição farmacêutica em forma de dosagem única

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100907144B1 (ko) * 2007-09-05 2009-07-09 박재섭 이동부재를 이용한 골프 클럽
WO2009024889A2 (en) * 2007-08-21 2009-02-26 Ranbaxy Laboratories Limited Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe
WO2011019326A2 (en) * 2009-07-02 2011-02-17 Mahmut Bilgic Solubility and stability enchancing pharmaceutical formulation
HUE038048T2 (hu) * 2009-07-28 2018-09-28 Egyt Gyogyszervegyeszeti Gyar Új granulálási eljárás és ezzel elõállított granulátum
EP2468258A1 (en) * 2010-12-22 2012-06-27 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
ES2802252T3 (es) * 2012-05-01 2021-01-18 Althera Life Sciences Llc Formulación de comprimido oral que consiste en la combinación fija de rosuvastatina y ezetimiba para el tratamiento de hiperlipidemia y enfermedades cardiovasculares

Also Published As

Publication number Publication date
JOP20150154B1 (ar) 2021-08-17
TW201625223A (zh) 2016-07-16
SG11201610748RA (en) 2017-01-27
ECSP16096477A (es) 2017-01-31
KR101977785B1 (ko) 2019-05-14
BR112016030111A2 (pt) 2017-08-22
WO2015199356A1 (en) 2015-12-30
KR20160000762A (ko) 2016-01-05
CL2016003283A1 (es) 2017-07-28
SG10201811586YA (en) 2019-02-27
UY36190A (es) 2015-10-30
TWI700100B (zh) 2020-08-01

Similar Documents

Publication Publication Date Title
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
JP2015078230A5 (ko)
UY27995A1 (es) Nuevas formulaciones farmacéuricas solidas que comprenden telmartisano y su preparación
PH12018501390A1 (en) Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
RS54329B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
RU2015110699A (ru) Фармацевтическая антиретровирусная композиция
MX2022015606A (es) Comprimidos de liberacion inmediata que contienen un farmaco y procesos para formar los comprimidos.
NZ628993A (en) Pharmaceutical formulations comprising ccr3 antagonists
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
TN2015000386A1 (en) Formulations of organic compounds
RU2019138248A (ru) Фармацевтическая композиция для перорального введения, содержащая энзалутамид
JP2017523149A5 (ko)
HRP20201155T1 (hr) Postupak dobivanja farmaceutskog pripravka koji sadrži derivat kinolina ili njegovu sol
MX2018008153A (es) Derivados de c-glicósido que tienen anillos de fenilo condensado o sales farmacéuticamente aceptables de los mismos, metodo para prepararlos y composición farmacéutica que los contiene.
AU2016231883B2 (en) Pharmaceutical compositions of dimethyl fumarate
EA033291B1 (ru) Единица дозирования, содержащая рамиприл и бисопролола гемифумарат, способ ее получения и способ лечения гипертензии
PE20160245A1 (es) Composicion farmaceutica anti-tuberculosis estable en una forma de un comprimido dispersable que comprende granulos de isoniazid y granulos de rifapentina y su proceso de preparacion
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
MY190027A (en) P38 map kinase inhibiting indanyl urea compounds
RU2013107724A (ru) Фармацевтические композиции монтелукаста и левоцетиризина
MX2019005005A (es) Tableta de liberacion extendida que comprende un farmaco de perdida de peso.
HRP20210969T1 (hr) Farmaceutski sastav koji sadrži darunavir i metoda za njegovu pripremu
EA202090842A1 (ru) Таблетки деферипрона с отсроченным высвобождением и способы их применения
PH12016502540A1 (en) Pharmaceutical dosage forms

Legal Events

Date Code Title Description
FC Refusal